Grants and Contracts Details
Borrelia mayonii is a newly-identified tick-borne pathogen of humans in the USA. Symptoms of B. mayonii infection include high-level bacteremia and diffuse macular rashes, which are distinct from those of its relative Borrelia burgdorferi, the Lyme disease agent. The proposed studies focus on elucidating the molecular mechanisms responsible for the unique pathogenic properties of B. mayonii.
|Effective start/end date||7/24/17 → 6/30/20|
- National Institute of Allergy and Infectious Diseases: $432,916.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.